Is tizanidine safe for use while breastfeeding?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 27, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Tizanidine Should Be Avoided During Breastfeeding

Tizanidine is not recommended for use while breastfeeding due to lack of safety data and its lipophilic properties that suggest likely passage into breast milk, with potential for infant sedation and CNS depression.

FDA Label Evidence

The FDA drug label explicitly states: "It is not known whether tizanidine is excreted in human milk, although as a lipid soluble drug, it might be expected to pass into breast milk" 1. This lack of human data, combined with the drug's pharmacologic properties, creates significant concern for infant safety.

Key Pharmacologic Concerns

Tizanidine's properties make it particularly problematic during lactation:

  • Lipid solubility: Facilitates transfer into breast milk
  • CNS depressant effects: Risk of infant sedation, drowsiness, and poor feeding
  • Alpha-2 adrenergic agonist activity: Central nervous system effects that could impact the infant
  • Long half-life considerations: Potential for accumulation with repeated maternal dosing

Expert Consensus

A 2013 systematic review of migraine medications during breastfeeding specifically lists tizanidine among preventive medications that are NOT recommended 2. This represents expert consensus from the American Headache Society's Women's Special Interest Section after reviewing multiple authoritative sources including LactMed, Hale's Medications and Mothers' Milk, and the American Academy of Pediatrics guidelines.

Clinical Decision-Making Algorithm

When a breastfeeding woman requires muscle relaxation:

  1. First-line alternatives: Consider physical therapy, NSAIDs (ibuprofen, diclofenac), or acetaminophen, all of which are safe during breastfeeding 3, 4

  2. If muscle relaxant necessary: Baclofen has more safety data in lactation and should be considered instead 5

  3. If tizanidine absolutely required:

    • Discuss risks with patient including potential infant sedation
    • Use lowest effective dose
    • Monitor infant closely for drowsiness, poor feeding, hypotonia
    • Consider temporary interruption of breastfeeding or pumping and discarding milk

Important Caveats

  • No human lactation studies exist for tizanidine, making risk assessment based entirely on theoretical concerns and pharmacologic properties
  • The drug's sedative effects could be additive with other CNS depressants the mother may be taking 1
  • Women taking oral contraceptives have 50% reduced clearance of tizanidine, potentially increasing milk concentrations 1

Practical Considerations

The absence of safety data is itself a critical finding. Unlike medications with established safety profiles during lactation (morphine, ibuprofen, local anesthetics), tizanidine lacks the clinical experience necessary to reassure about infant safety 3, 4. When evidence is absent for a CNS-active, lipophilic medication, the prudent clinical approach is avoidance.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.